Begelomab (Anti-DPP4 / CD26)
Products
Description
Begelomab (Anti-DPP4 / CD26) is a monoclonal antibody targeting DPP-4/CD26. Begelomab can be used for the research of severe refractory idiopathic inflammatory myopathy. MW: 145.5 KD.
Specifications
| Manufacturer Cat# | A2517 |
|---|---|
| Target | DPP |